Confo Therapeutics
Exploiting the conformational complexity of GPCRs to innovate drug discovery
82 employees · est. 2015 · Zwijnaarde, Belgium
Design Pharmaceuticals Inc.
Boundless GPCR drug discovery
3 employees · est. 2018 · Cambridge, United States
Confo Therapeutics is the older company (2015 vs 2018); Confo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Confo Therapeutics | Design Pharmaceuticals Inc. |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2018 |
| Headquarters | ||
| Headquarters | Zwijnaarde, Belgium | Cambridge, United States |
| Employees | ||
| Employees | 82 larger | 3 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Seed |
| Total Funding | ||
| Total Funding | Not tracked yet | $5.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 1 |
| Services | ||
| Services | Development of GPCR-modulating therapies, Clinical research and development, Partnership with pharmaceutical companies, Small molecules and antibody therapeutics development, GPCR targeting technology innovation | Interior design consultations, Product lines in textiles and lighting, Public speaking and lectures, Brand representation and ambassadorship, Digital home management solutions, Virtual design consultations |
| Target Customers | ||
| Target Customers | Patients with metabolic diseases, Patients with endocrine diseases, Pharmaceutical companies, Healthcare providers specializing in pain management, Research institutions | Homeowners, Interior design enthusiasts, Furniture and home product retailers, Design studios, Event organizers for speaking engagements |
| Taxonomy | ||
| Taxonomy | GPCR Drug Discovery, Conformational Stabilization, Biopharmaceuticals, Drug Candidates Development, Severe Illness Therapeutics, Disease-Modifying Treatments, Pharmacologic Insight, Biologic Insight, Innovative Drug Targets, CONFO® Technology, Active State Conformations, Novel Agonist Discovery, Antibody Technology, Multi-Indication Pipeline, Unmet Medical Needs | GPCR Drug Discovery, Ultra-high Throughput Bioscience, Therapeutic Market, Cell-based Screening Platform, Drug Development, Microfluidics, Pharmaceutical Research, NGS Technology, Therapeutic Innovation, Biologics Libraries, Compound Screening, Drug Function Assays, Targeted Therapies, Innovative Drug Discovery |
| Website | ||
| Website | confotherapeutics.com | designpharmaceuticals.com |
About Confo Therapeutics
Confo Therapeutics, founded in 2015 and headquartered in Belgium, is a pioneering biotechnology company that leverages its proprietary technology platform to stabilize functional conformations of GPCRs (G protein-coupled receptors). This innovative approach uncovers a vast array of previously inacce...
About Design Pharmaceuticals Inc.
Design Pharmaceuticals Inc., founded in 2018, is carving out a niche in the Biotechnology, Health Care, and Pharmaceutical sectors with its innovative approach to GPCR drug discovery. With the slogan "Boundless GPCR drug discovery", the company aims to revolutionize the market by dramatically accele...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Confo Therapeutics and Design Pharmaceuticals Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Confo Therapeutics and Design Pharmaceuticals... — by email.
Frequently Asked Questions
Compare Confo Therapeutics with someone else
Start typing a company name or domain.